ISRCTN21444964已完成未知
Vitamin K therapy to improve vascular health in patients with chronic kidney disease: a randomised controlled trial
Tayside Academic Science Centre (NHS Tayside and University of Dundee)0 个研究点目标入组 159 人开始时间: 2015年2月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 159
研究概览
简要总结
2020 results in https://pubmed.ncbi.nlm.nih.gov/32817311/ (added 24/08/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age >18 years
- •2. CKD stages 3b or 4 (eGFR of >15 ml/min and <45 ml/min by MDRD4 equation)
排除标准
- •1. Atrial fibrillation
- •2. Taking warfarin (which antagonises vitamin K) or other coumadin derivatives.
- •3. Taking vitamin K
- •4. Unable to give written informed consent
- •5. Currently enrolled in another trial, or within 30 days of completing another trial
- •6. Pregnant or (if female and pre-menopausal) not using reliable contraception
研究者
相似试验
已完成
不适用
Vitamin K to improve markers of vascular health and physical function in older people with vascular diseaseISRCTN93213492Tayside Academic Sciences Collaboration (UK)80
已完成
不适用
ow dose vitamin K to improve therapeutic quality control of oral anticoagulant treatment: a randomised double-blind placebo controlled trialThrombosis, emboly, anticoagulant treatmentHaematological DisordersAnticoagulant treatmentISRCTN14473912eiden University Medical Center (LUMC) (The Netherlands)200
已完成
不适用
ow dose vitamin K to improve therapeutic quality control of oral anticoagulant treatment: a randomized double-blind placebo controlled trial.NL-OMON25820Trombosestichting Nederland200
已完成
4 期
Vitamin k1 and Its Relation to Vascular Calcification in Hemodialysis PatientsVascular CalcificationNCT05060809Assiut University120
已完成
不适用
Dose-finding Study for Vitamin K2 in Human VolunteersVitamin K-statusNCT00483431Maastricht University Medical Center42